149 related articles for article (PubMed ID: 3037205)
21. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.
Cooper EH; Splinter TA; Brown DA; Muers MF; Peake MD; Pearson SL
Br J Cancer; 1985 Sep; 52(3):333-8. PubMed ID: 2994704
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer.
Jaques G; Bepler G; Holle R; Wolf M; Hannich T; Gropp C; Havemann K
Cancer; 1988 Jul; 62(1):125-34. PubMed ID: 2838147
[TBL] [Abstract][Full Text] [Related]
23. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
[TBL] [Abstract][Full Text] [Related]
24. [Determination of tumor markers NSE and CEA in patients with various lung diseases, especially carcinomas].
Velcovsky HG; Hofmann H; Discher T; Laumen R; Jungbluth H
Immun Infekt; 1986 Feb; 14(1):32-4. PubMed ID: 3957406
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
[TBL] [Abstract][Full Text] [Related]
26. Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung.
Nikliński J; Furman M; Palynyczko Z; Laudański J; Bułatowicz J
Neoplasma; 1991; 38(6):645-51. PubMed ID: 1766488
[TBL] [Abstract][Full Text] [Related]
27. [A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer].
Ueoka H; Ohnoshi T; Moritaka T; Kiura K; Mima Y; Horiguchi T; Segawa Y; Tabata M; Shibayama T; Maeda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Aug; 29(8):1022-8. PubMed ID: 1684395
[TBL] [Abstract][Full Text] [Related]
28. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
29. [Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer].
Mori Y; Hoshi H; Jinnouchi S; Harada K; Onoe K; Nagamachi S; Ozawa M; Watanabe K; Tawara Y
Radioisotopes; 1987 Feb; 36(2):78-80. PubMed ID: 3033753
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
Seemann MD; Beinert T; Fürst H; Fink U
Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
[TBL] [Abstract][Full Text] [Related]
31. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):452-5. PubMed ID: 2552209
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
Lee JH; Chang JH
Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
[TBL] [Abstract][Full Text] [Related]
33. Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).
Ferrigno D; Buccheri G; Giordano C
Lung Cancer; 2003 Sep; 41(3):311-20. PubMed ID: 12928122
[TBL] [Abstract][Full Text] [Related]
34. Neuron-specific enolase, thymidine kinase, and tissue polypeptide-specific antigen in diagnosis and response to chemotherapy of small-cell lung cancer.
Abbasciano V; Sartori S; Trevisani L; Nielsen I; Ferrazzi E; Bononi A; Toso S; Crepaldi G; Bianchi MP; Gilli G; Zavagli G
Cancer Detect Prev; 1999; 23(4):309-15. PubMed ID: 10403902
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
Plebani M; Basso D; Navaglia F; De Paoli M; Tommasini A; Cipriani A
Br J Cancer; 1995 Jul; 72(1):170-3. PubMed ID: 7541234
[TBL] [Abstract][Full Text] [Related]
36. Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
Shimokata K; Niwa Y; Yamamoto M; Sasou H; Morishita M
Chest; 1989 Mar; 95(3):602-3. PubMed ID: 2537710
[TBL] [Abstract][Full Text] [Related]
37. [Clinical evaluation of serum NSE and CEA in primary lung cancer patients].
Fukasawa T; Fujisawa T; Yamaguchi Y; Sasaki K; Shiba M; Yusa T; Sakio H; Momiki S; Ogawa T
Gan To Kagaku Ryoho; 1986 May; 13(5):1862-7. PubMed ID: 3010884
[TBL] [Abstract][Full Text] [Related]
38. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
39. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA
Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878
[TBL] [Abstract][Full Text] [Related]
40. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
Schneider J; Philipp M; Salewski L; Velcovsky HG
Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
